Donald Bergstrom
Chief Tech/Sci/R&D Officer at RELAY THERAPEUTICS, INC.
Net worth: 4 M $ as of 2024-03-30
Profile
Donald A.
Bergstrom is currently an Independent Director at Cellectis SA, a Director at Cellectis, Inc., an Independent Director at Fusion Pharmaceuticals, Inc., and the President-Research & Development at Relay Therapeutics, Inc. He previously served as the Chief Medical Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2014 to 2018 and as the Global Head-Translational & Experimental Medicine at Sanofi-Aventis U.S.
LLC from 2010 to 2014.
He also worked as a Principal at Merck Research Laboratories Massachusetts LLC.
Dr. Bergstrom holds a doctorate degree from the University of Washington and an undergraduate degree from The Johns Hopkins University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
RELAY THERAPEUTICS, INC.
0.40% | 2024-03-26 | 530,113 ( 0.40% ) | 4 M $ | 2024-03-30 |
2023-06-13 | 0 ( -.--% ) | - $ | 2024-03-30 |
Donald Bergstrom active positions
Companies | Position | Start |
---|---|---|
RELAY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-03-31 |
FUSN PHAR | Director/Board Member | 2021-03-31 |
CELLECTIS S.A. | Director/Board Member | 2022-06-27 |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Director/Board Member | - |
Former positions of Donald Bergstrom
Companies | Position | End |
---|---|---|
MERSANA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-03-30 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 2013-12-31 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | - |
Training of Donald Bergstrom
University of Washington | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
MERSANA THERAPEUTICS, INC. | Health Technology |
CELLECTIS S.A. | Health Technology |
RELAY THERAPEUTICS, INC. | Health Technology |
FUSN PHAR | Health Technology |
Private companies | 3 |
---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |
- Stock Market
- Insiders
- Donald Bergstrom